ZAP-70 in chronic lymphocytic leukemia [4] (multiple letters)

New England Journal of Medicine

Volumn 349, Issue 5, 2003, Pages 506-507

  Murashige, Naoko ^a   Kami, Masahiro ^a   Takaue, Yoichi ^a   Bosch, Francesc ^b   Villamor, Neus ^b   Montserrat, Emili ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; FLUDARABINE; PROTEIN KINASE ZAP 70; TUMOR MARKER; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE KINASE; ZAP70 PROTEIN, HUMAN;

CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; HUMAN; LETTER; PRIORITY JOURNAL; AGE; AGED; EPIDEMIOLOGY; METABOLISM; NOTE; PROGNOSIS;

AGE FACTORS; AGED; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; PROGNOSIS; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SELECTION BIAS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0041342007     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200307313490518     Document Type: Letter

References (0)